IDO1 antibody

Synonyms:CD107B antibody, IDO antibody, IDO 1 antibody, IDO1 antibody, INDO antibody, indoleamine 2 antibody, 3 dioxygenase 1 antibody
Catalogue No.:FNab04127Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, IHC, WB
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
IDO1 antibody
Catalogue No.
FNab04127
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
indoleamine 2,3-dioxygenase 1
Alternative Names
CD107B antibody, IDO antibody, IDO 1 antibody, IDO1 antibody, INDO antibody, indoleamine 2 antibody, 3 dioxygenase 1 antibody
UniProt ID
P14902
Observed MW
42 kDa
Application
Tested Applications
ELISA, IHC, WB
Recommended dilution
WB: 1:1000-1:4000; IHC: 1:50-1:500
Validated Images
Hela cells were subjected to SDS PAGE followed by western blot with FNab04127( IDO1 Antibody) at dilution of 1:2000
Immunohistochemistry of paraffin-embedded human tonsillitis tissue slide using FNab04127( IDO1 Antibody) at dilution of 1:100
Background
Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway(PubMed:17671174). Involved in the peripheral immune tolerance, contributing to maintain homeostasis by preventing autoimmunity or immunopathology that would result from uncontrolled and overreacting immune responses(PubMed:25691885). Tryptophan shortage inhibits T lymphocytes division and accumulation of tryptophan catabolites induces T-cell apoptosis and differentiation of regulatory T-cells(PubMed:25691885). Acts as a suppressor of anti-tumor immunity(PubMed:23103127, PubMed:25157255, PubMed:14502282, PubMed:25691885). Limits the growth of intracellular pathogens by depriving tryptophan(PubMed:25691885). Protects the fetus from maternal immune rejection(PubMed:25691885).